Neoplastic Pericardial Effusion: A Monocentric Retrospective Study
Elisabetta Di Liso(Istituti di Ricovero e Cura a Carattere Scientifico), PierFranco Conte(University of Padua), Federica Miglietta(University of Padua), Cristina Ghiotto(Istituto Oncologico Veneto), Giulia Zago(Istituto Oncologico Veneto), Valentina Guarneri(Istituto Oncologico Veneto), Giovanna Pintacuda(Istituto Oncologico Veneto), Marta Padovan(University of Padua), Floriana Nappo(University of Padua), Alessandra Bianchi(Istituto Oncologico Veneto), Alice Menichetti(University of Padua), L. Corti(Istituto Oncologico Veneto), A. Banzato(Istituto Oncologico Veneto), Enrico Cumerlato(University of Padua), Maria Vittoria Dieci(Istituto Oncologico Veneto), Eleonora Mioranza(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 11
Related Papers
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
|IRIS UNIMORE (University of Modena and Reggio Emilia)|2005|1.6k
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
|JAMA Oncology|2019|983
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830